Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort-Reference-Cited by-同舟云学术

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort

Published:2019-04-30 Issue:4 Volume:145 Page:1033-1041
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bonde Jesper¹^ORCID,Bottari Fabio²,Parvu Valentin³,Pedersen Helle¹,Yanson Karen³,Iacobone Anna D.⁴,Kodsi Salma³,Landoni Fabio⁵,Vaughan Laurence³,Ejegod Ditte M.¹,Sandri Maria T.⁶

Affiliation:

1. Molecular Pathology Laboratory, Department of PathologyCopenhagen University, Hvidovre Hospital Hvidovre Denmark

2. Laboratory Medicine DivisionEuropean Institute of Oncology Milan Italy

3. Becton Dickinson and Company Sparks MD USA

4. Preventive Gynecology UnitEuropean Institute of Oncology Milan Italy

5. Department of Medicine and SurgeryUniversity of Milan Bicocca Milan Italy

6. Laboratorio Analisi ClinicheHumanitas Research Hospital Milan Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32291

Reference48 articles.

1. Human papillomavirus and cervical cancer

2. Adding a Test for Human Papillomavirus DNA to Cervical-Cancer Screening

3. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

4. Heterogeneity in CIN3 diagnosis

5. Cervical cancer screening at crossroads

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of a vaginal self-collection device versus clinician collected cervical samples for the detection of high-risk human papillomavirus;Preventive Medicine Reports;2024-05

2. Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening;Cancers;2024-03-28

3. Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening;Journal of Clinical Virology;2024-02

4. Clinical use of the Onclarity test with extended HPV genotyping and phenotyping in patients with suspected squamous intraepithelial lesions;Ginekologia Polska;2023-12-11

5. Impact of cervical screening by human papillomavirus genotype: Population-based estimations;PLOS Medicine;2023-10-27